LL-37 (Cathelicidin) is a 37-amino acid human antimicrobial peptide derived from the cathelicidin hCAP18. It is studied for its broad-spectrum antimicrobial (bacteria, viruses, fungi), immunomodulatory, and innate biological defense properties.
Composition
5 mg per vial
Experimental Exposure (Research)
Research exposure: 50–300 mcg
Studied for its antimicrobial and immunomodulatory action
Exclusive use in a controlled scientific environment
Informational Benefits (Research)
Studies on natural antimicrobial properties
Research on immune modulation
Potential support for tissue repair
Analysis of anti-inflammatory effects
Exploration of its role in biological defense
Studies on microbiome balance
For research use only - Not for human consumption.
